UNLABELLED: Background- Combined hyperlipidemia is a common disorder characterized by a highly atherogenic lipoprotein profile and increased risk of coronary heart disease. The etiology of the lipid abnormalities (increased serum cholesterol and triglyceride or either lipid alone) is unknown. METHODS AND RESULTS: We assembled 2 large cohorts of families with familial combined hyperlipidemia (FCHL) and performed disease and quantitative trait linkage analyses to evaluate the inheritance of the lipid abnormalities. Chromosomal regions 6q16.1-q16.3, 8p23.3-p22, and 11p14.1-q12.1 produced evidence for linkage to FCHL. Chromosomes 6 and 8 are newly identified candidate loci that may respectively contribute to the triglyceride (logarithm of odds [LOD], 1.43; P=0.005) and cholesterol (LOD, 2.2; P=0.0007) components of this condition. The data for chromosome 11 readily fulfil the guidelines required for a confirmed linkage. The causative alleles may contribute to the inheritance of the cholesterol (LOD, 2.04 at 35.2 cM; P=0.0011) component of FCHL as well as the triglyceride trait (LOD, 2.7 at 48.7 cM; P=0.0002). CONCLUSIONS: Genetic analyses identify 2 potentially new loci for FCHL and provide important positional information for cloning the genes within the chromosome 11p14.1-q12.1 interval that contributes to the lipid abnormalities of this highly atherogenic disorder.
UNLABELLED: Background- Combined hyperlipidemia is a common disorder characterized by a highly atherogenic lipoprotein profile and increased risk of coronary heart disease. The etiology of the lipid abnormalities (increased serum cholesterol and triglyceride or either lipid alone) is unknown. METHODS AND RESULTS: We assembled 2 large cohorts of families with familial combined hyperlipidemia (FCHL) and performed disease and quantitative trait linkage analyses to evaluate the inheritance of the lipid abnormalities. Chromosomal regions 6q16.1-q16.3, 8p23.3-p22, and 11p14.1-q12.1 produced evidence for linkage to FCHL. Chromosomes 6 and 8 are newly identified candidate loci that may respectively contribute to the triglyceride (logarithm of odds [LOD], 1.43; P=0.005) and cholesterol (LOD, 2.2; P=0.0007) components of this condition. The data for chromosome 11 readily fulfil the guidelines required for a confirmed linkage. The causative alleles may contribute to the inheritance of the cholesterol (LOD, 2.04 at 35.2 cM; P=0.0011) component of FCHL as well as the triglyceride trait (LOD, 2.7 at 48.7 cM; P=0.0002). CONCLUSIONS: Genetic analyses identify 2 potentially new loci for FCHL and provide important positional information for cloning the genes within the chromosome 11p14.1-q12.1 interval that contributes to the lipid abnormalities of this highly atherogenic disorder.
Authors: M De Michele; A Iannuzzi; A Salvato; P Pauciullo; M Gentile; G Iannuzzo; S Panico; A Pujia; G M Bond; P Rubba Journal: Heart Date: 2006-06-28 Impact factor: 5.994
Authors: Adriana López-Barradas; Tania González-Cid; Norma Vázquez; Marisol Gavi-Maza; Adriana Reyes-Camacho; Laura A Velázquez-Villegas; Victoria Ramírez; Kambiz Zandi-Nejad; David B Mount; Nimbe Torres; Armando R Tovar; Michael F Romero; Gerardo Gamba; Consuelo Plata Journal: Am J Physiol Cell Physiol Date: 2016-08-03 Impact factor: 4.249
Authors: Daphna Weissglas-Volkov; Christopher L Plaisier; Adriana Huertas-Vazquez; Ivette Cruz-Bautista; Daniela Riaño-Barros; Miguel Herrera-Hernandez; Laura Riba; Rita M Cantor; Janet S Sinsheimer; Carlos A Aguilar-Salinas; Teresa Tusie-Luna; Päivi Pajukanta Journal: Arterioscler Thromb Vasc Biol Date: 2009-12-03 Impact factor: 8.311
Authors: Christopher L Plaisier; Mira Kyttälä; Daphna Weissglas-Volkov; Janet S Sinsheimer; Adriana Huertas-Vazquez; Laura Riba; Salvador Ramírez-Jiménez; Tjerk W A de Bruin; Teresa Tusié-Luna; Bradley E Aouizerat; Clive R Pullinger; Mary J Malloy; John P Kane; Ivette Cruz-Bautista; Miguel F Herrera; Carlos Aguilar-Salinas; Johanna Kuusisto; Markku Laakso; Marja-Riitta Taskinen; Carla J H van der Kallen; Päivi Pajukanta Journal: Arterioscler Thromb Vasc Biol Date: 2008-11-06 Impact factor: 8.311
Authors: Elizabeth R Hauser; David C Crossman; Christopher B Granger; Jonathan L Haines; Christopher J H Jones; Vincent Mooser; Brendan McAdam; Bernhard R Winkelmann; Alan H Wiseman; J Brent Muhlestein; Alan G Bartel; Charles A Dennis; Elaine Dowdy; Susan Estabrooks; Karen Eggleston; Sheila Francis; Kath Roche; Paula W Clevenger; Liling Huang; Bonnie Pedersen; Svati Shah; Silke Schmidt; Carol Haynes; Sandra West; Donny Asper; Michael Booze; Sanjay Sharma; Scott Sundseth; Lefkos Middleton; Allen D Roses; Michael A Hauser; Jeffery M Vance; Margaret A Pericak-Vance; William E Kraus Journal: Am J Hum Genet Date: 2004-07-22 Impact factor: 11.025
Authors: Donna K Arnett; Michael B Miller; Hilary Coon; R Curtis Ellison; Kari E North; Michael Province; Mark Leppert; John H Eckfeldt Journal: Hum Genet Date: 2004-09-16 Impact factor: 4.132
Authors: Corina Shtir; I Sharon Nagakawa; William L Duren; Karen N Conneely; Laura J Scott; Kaisa Silander; Timo T Valle; Jaakko Tuomilehto; Thomas A Buchanan; Richard N Bergman; Francis S Collins; Michael Boehnke; Richard M Watanabe Journal: Hum Hered Date: 2006-12-14 Impact factor: 0.444
Authors: Stuart D Horswell; Lee G D Fryer; Claire E Hutchison; Dlear Zindrou; Helen E Speedy; Margaret-M Town; Emma J Duncan; Rasheeta Sivapackianathan; Hetal N Patel; Emma L Jones; Adam Braithwaite; Max P A Salm; Claire K Y Neuwirth; Elizabeth Potter; Jonathan R Anderson; Kenneth M Taylor; Mary Seed; D John Betteridge; Martin A Crook; Anthony S Wierzbicki; James Scott; Rossi P Naoumova; Carol C Shoulders Journal: J Lipid Res Date: 2013-10-08 Impact factor: 5.922
Authors: Jun Wu; Michael A Province; Hilary Coon; Steven C Hunt; John H Eckfeldt; Donna K Arnett; Gerardo Heiss; Cora E Lewis; R Curtis Ellison; Dabeeru C Rao; Treva Rice; Aldi T Kraja Journal: BMC Genet Date: 2007-09-10 Impact factor: 2.797